LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 207 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,332,000 | +10.9% | 8,622 | 0.0% | 0.14% | +2.1% |
| Q3 2021 | $1,201,000 | +6.2% | 8,622 | 0.0% | 0.14% | +7.7% |
| Q2 2021 | $1,131,000 | -13.9% | 8,622 | 0.0% | 0.13% | -7.1% |
| Q1 2021 | $1,314,000 | +53.3% | 8,622 | 0.0% | 0.14% | +62.8% |
| Q4 2020 | $857,000 | +100.2% | 8,622 | +91.9% | 0.09% | +56.4% |
| Q3 2020 | $428,000 | -32.7% | 4,494 | -21.0% | 0.06% | -35.3% |
| Q2 2020 | $636,000 | +150.4% | 5,687 | +181.5% | 0.08% | +347.4% |
| Q1 2019 | $254,000 | -62.9% | 2,020 | -59.9% | 0.02% | -65.5% |
| Q4 2018 | $684,000 | -59.1% | 5,040 | -17.3% | 0.06% | +48.6% |
| Q3 2018 | $1,673,000 | +296.4% | 6,096 | +199.0% | 0.04% | +362.5% |
| Q2 2018 | $422,000 | -73.9% | 2,039 | -93.1% | 0.01% | -55.6% |
| Q3 2014 | $1,617,000 | +75.4% | 29,600 | +100.0% | 0.02% | -14.3% |
| Q2 2014 | $922,000 | +191.8% | 14,800 | +214.9% | 0.02% | +200.0% |
| Q1 2014 | $316,000 | +62.1% | 4,700 | +27.0% | 0.01% | +40.0% |
| Q4 2013 | $195,000 | – | 3,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |